echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurol Neuroimmunol Neuroinflamm: OCT to check the thickness of the retinal layer helps early recognition of the risk of cognitive impairment in patients with multiple sclerosis

    Neurol Neuroimmunol Neuroinflamm: OCT to check the thickness of the retinal layer helps early recognition of the risk of cognitive impairment in patients with multiple sclerosis

    • Last Update: 2021-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For patients with multiple sclerosis (MS), cognitive impairment (CI) may be a prominent symptom of the disease, even in the early stages.


    The retinal layer thickness (RLT) measured by optical coherence tomography (OCT) is considered to be a non-invasive, cost-effective and effective marker of multiple sclerosis (MS) neurodegeneration.


    The study data comes from a baseline examination of an intervention study.


    The figure above shows the exclusion, withdrawal, and final sample situation.


    In this cross-sectional study, patients with at least signs of mild cognitive impairment were examined by OCT, the International MS Cognitive Assessment, and the Attention and Executive Function Test (Trail Making Test [TMT] A and B).


    A total of 64 patients entered the study.


    Scatter plot of the correlation between cognitive performance of pRNFL, mRNFL, GCIPL and TMT-B

    Scatter plot of the correlation between cognitive performance of pRNFL, mRNFL, GCIPL and TMT-B

    The figure above depicts the raw scores of cognitive performance for each RLT extreme group.


     

    In MS patients, at the lower stage of the disease, RLT is particularly related to cognitive flexibility, promoting OCT as a potential marker and advocating further extensive neuropsychological examinations.


    In summary, RLT and BICAMS seem to be complementary methods in patients with mild to moderate clinical deficits, because SDMT and BVMT-R have no correlation with RLT when correcting for multiple tests.


    Diagnosing OCT may provide opportunities to identify MS patients at risk of CI in a cost-effective and feasible way as early as possible.


    neurology.


    neurology.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.